01 · The Goal

Regrow bone where injury and disease destroy it

The goal is to regrow living bone — to rebuild density lost to osteoporosis and to regenerate bone destroyed by injury or disease — so the skeleton is restored to strength rather than left to weaken.

02 · Why It Matters

Bone is living, constantly-remodeled tissue, and it heals fractures well. But two things defeat it: osteoporosis, where breakdown outpaces building and bones thin until a fall breaks a hip; and large bone defects from trauma or disease that exceed what the body can bridge on its own. Bone loss and fragility cause enormous disability, especially with age. Regrowing bone — rebuilding density and lost volume — keeps the skeleton strong for life. That is why it is the flagship of bones.

03 · What We’re Trying to Achieve

We are building the capability to rebuild bone density and regenerate missing bone: therapies that actively add bone (not just slow loss), and scaffolds plus cells and growth factors that regrow bone to rebuild lost volume and bond into the living skeleton.

04 · How It Works

Building density and regrowing missing bone

Rebuilding bone density Clinical

Bone-building therapies can do more than slow loss — some actively rebuild bone density and cut fracture risk, in clinical use today.

Scaffold bone regeneration Demonstrated

Engineered scaffolds seeded with bone-forming cells and growth factors regrow bone to rebuild the volume injury and disease leave behind.

Accelerating fracture healing Demonstrated

Growth factors and stem-cell approaches speed healing and mend fractures that would otherwise fail to unite.

Directing the body’s bone cells Frontier

Tuning the balance between bone-building and bone-removing cells aims to tip the skeleton toward growth at any age.

05 · Who’s Building It

Cited as evidence the capability is real — not as partners or endorsers.

Universities & institutes

Academic orthopedic, bone-biology, and biomaterials research centers developing scaffolds, cells, and bone-building therapies.

Government & programs

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, NIH) · National Institute on Aging · NIH and DoD regenerative programs · AFIRM.

Enabling science base

bone remodeling biology · bone stem cells · osteoporosis therapeutics · bone scaffolds & biomaterials · growth factors (e.g. BMPs).

06 · Technologies

The technologies: anabolic (bone-building) therapeutics; bone scaffolds and biomaterials that provide a structure for regrowth; bone stem cells and growth factors (such as BMPs) that drive new bone; and the remodeling biology that governs the balance between building and removing bone.

07 · Breakthroughs

Density-rebuilding therapies in use Clinical

Therapies that actively rebuild bone density — not merely slow loss — are in clinical use and reduce fractures.

Scaffold-regrown bone Demonstrated

Cell-and-scaffold constructs regrow bone to rebuild lost volume in clinical and research settings.

Faster fracture union Demonstrated

Growth-factor and stem-cell approaches accelerate fracture healing, including for non-healing breaks.

Balance-tuning research Frontier

Work to retune the bone-cell balance toward growth at any age is advancing in the lab.

08 · Remaining Challenges

The honest challenges: regrowing large bone defects fully — at the right shape and strength, integrated with living bone and blood supply — is still being perfected. Vascularization of big grafts is hard. And bone-building must stay balanced and safe over the long term. Density rebuilding and scaffold regrowth are clinical or advancing fast; complete regrowth of major defects remains advancing-to-frontier, labeled honestly.

09 · Mature Capability

The future, fully built

A person with thinning or destroyed bone has the skeleton rebuilt: density restored, fractures healed quickly, missing bone regrown and integrated, frailty prevented. Strong bone becomes something we rebuild, not lose with age.

Honest boundary: each item is tagged for where it stands — demonstrated, clinical, or frontier. The science is real, funded, and accelerating. AI supports human clinicians; it never replaces them.
10 · Evidence Vault

The proof, for this capability

Cited as evidence the capability is real, not as partners or endorsers.

Bone-density rebuilding therapies

Anabolic therapies actively rebuild bone density and cut fractures, in clinical use. Stage: Clinical.

Scaffold bone regeneration

Cell-and-scaffold constructs regrow bone to rebuild lost volume. Stage: Demonstrated.

Fracture-healing acceleration

Growth factors and stem cells speed and rescue fracture healing. Stage: Demonstrated.

Honest framing

Real organizations are cited as evidence the capability is real — not as partners or endorsers. Full regrowth of large defects is still being perfected; we do not claim it is routine.

Help build this future

Every signature grows the movement to make bone regeneration real — and free at the point of need.

Paid for by Michael Floyd for President.

Scroll to Top